517 related articles for article (PubMed ID: 30122854)
1. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
[TBL] [Abstract][Full Text] [Related]
2. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis.
Patel P; Finger PT
Am J Ophthalmol; 2012 Apr; 153(4):661-8. PubMed ID: 22264690
[TBL] [Abstract][Full Text] [Related]
3. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
[TBL] [Abstract][Full Text] [Related]
4. Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients.
Freton A; Chin KJ; Raut R; Tena LB; Kivelä T; Finger PT
Eur J Ophthalmol; 2012; 22(2):236-43. PubMed ID: 21959680
[TBL] [Abstract][Full Text] [Related]
5. Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
Chin K; Finger PT; Kurli M; Tena LB; Reddy S
Optometry; 2007 Aug; 78(8):396-401. PubMed ID: 17662928
[TBL] [Abstract][Full Text] [Related]
6. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ
Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
[TBL] [Abstract][Full Text] [Related]
7. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
8. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
9. Importance of PET/CT examination in patients with malignant uveal melanoma.
Marko M; Leško P; Jurenová D; Furda R; Greguš M
Cesk Slov Oftalmol; 2020; 76(1):37-44. PubMed ID: 32917093
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
11. Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.
Kurli M; Chin K; Finger PT
Br J Ophthalmol; 2008 Apr; 92(4):479-82. PubMed ID: 18369064
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Ultrasonography Compared With Computed Tomography and Magnetic Resonance Imaging at Diagnosis of Metastatic Uveal Melanoma.
Rantala ES; Peltola E; Helminen H; Hernberg M; Kivelä TT
Am J Ophthalmol; 2020 Aug; 216():156-164. PubMed ID: 32278769
[TBL] [Abstract][Full Text] [Related]
13. Whole body PET/CT for initial staging of choroidal melanoma.
Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC
Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114
[TBL] [Abstract][Full Text] [Related]
14. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
[TBL] [Abstract][Full Text] [Related]
15. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
[TBL] [Abstract][Full Text] [Related]
16. Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging.
Beyer T; Pietrzyk U; Knoess C; Vollmar S; Wienhard K; Kracht L; Bockisch A; Maderwald S; Kühl H; Fitzek M
Nuklearmedizin; 2008; 47(2):73-9. PubMed ID: 18392316
[TBL] [Abstract][Full Text] [Related]
17. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
[TBL] [Abstract][Full Text] [Related]
18. Patients presenting with stage IV uveal melanoma: Lessons learned.
Garg G; Kivelä TT; Finger PT
Indian J Ophthalmol; 2022 Jan; 70(1):271-274. PubMed ID: 34937253
[TBL] [Abstract][Full Text] [Related]
19. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
Klingenstein A; Haug AR; Zech CJ; Schaller UC
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):158-65. PubMed ID: 22526099
[TBL] [Abstract][Full Text] [Related]
20. Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma.
Patel M; Winston CB; Marr BP; Carvajal RD; Schwartz GK; Wolchok J; Busam K; Abramson DH
Arch Ophthalmol; 2011 Dec; 129(12):1576-82. PubMed ID: 22159677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]